Archive for the 'Lipitor lawsuit' Category
Sunday 21 June 2009 @ 5:37 am
Recent cases and decisions
Wednesday 17 June 2009 @ 11:58 pm
Medicis Pharmaceutical Corporation, a US-based skincare drug manufacturer, has filed a lawsuit against Daiichi Sankyo-owned Ranbaxy Pharmaceuticals for alleged infringement of its patent on Solodyn, a minocycline hydrochloride extended-release tablet used to treat acne.
Wednesday 17 June 2009 @ 4:58 pm
Medicis Pharmaceutical Corporation, a US-based skincare drug manufacturer, has filed a lawsuit against Daiichi Sankyo-owned Ranbaxy Pharmaceuticals for alleged infringement of its patent on Solodyn, a minocycline hydrochloride extended-release tablet used to treat acne.
Wednesday 17 June 2009 @ 4:58 pm
Medicis Pharmaceutical Corporation, a US-based skincare drug manufacturer, has filed a lawsuit against Daiichi Sankyo-owned Ranbaxy Pharmaceuticals for alleged infringement of its patent on Solodyn, a minocycline hydrochloride extended-release tablet used to treat acne.
Wednesday 17 June 2009 @ 2:57 pm
Medicis Pharmaceutical Corporation, a US-based skincare drug manufacturer, has filed a lawsuit against Daiichi Sankyo-owned Ranbaxy Pharmaceuticals for alleged infringement of its patent on Solodyn, a minocycline hydrochloride extended-release tablet used to treat acne.
Tuesday 16 June 2009 @ 4:59 pm
US-based speciality pharma company Medicis Pharma Corporation has filed a suit against Delaware-based Ranbaxy Inc, a wholly-owned subsidiary of Ranbaxy Laboratories Ltd, in the district court of Delaware, alleging patent infringement of its acne product-solodyn tablets.
Monday 15 June 2009 @ 2:41 pm
June 15 (Bloomberg) -- Pfizer Inc. , the world’s biggest drugmaker, sued rival Mylan Inc. asking a judge to prohibit sales of a generic version of its cholesterol-fighting medicine Lipitor until 2017.
Friday 12 June 2009 @ 6:47 pm
Medicis Pharmaceutical Corp. filed suit against Ranbaxy Inc. and Ranbaxy Laboratories Ltd. for allegedly trying to market a generic version of Medicis’ Solodyn, according to an 8-K filing with the U.S. Securities and Exchange Commission.
Friday 12 June 2009 @ 1:41 pm
June 12 (Bloomberg) -- Wyeth agreed to settle a consolidated lawsuit filed in Delaware by shareholders over claims they are being shortchanged in Pfizer Inc.
Friday 12 June 2009 @ 1:33 pm
June 12 (Bloomberg) -- Wyeth agreed to settle a consolidated lawsuit filed in Delaware by shareholders over claims they are being shortchanged in Pfizer Inc.



